Castle Biosciences reaffirms its revenue guidance for 2023 and targets for 2025, with expected revenue of $170-$180 million for 2023 and $255-$330 million for 2025, as well as achieving net operating cash flow positivity by 2025.
AI Assistant
CASTLE BIOSCIENCES INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.